Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2021

Jul 27, 2021

61176_rns_2021-07-27_94bc4d1f-fbeb-468d-9d2c-f162710b00cb.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India

T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

July 27, 2021

To To
The Secretary The Secretary
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001 Mumbai – 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date Name Type of meeting Location
July 27, 2021 FSSA Investment Managers Teleconference Bangalore
July 27, 2021 LIC Mutual Funds Teleconference Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

_______________

Mayank Verma Company Secretary and Compliance Officer